We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
-1.48%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$475M
AUM Growth
-$34.1M
Cap. Flow
-$11.9M
Cap. Flow %
-2.51%
Top 10 Hldgs %
32.02%
Holding
95
New
18
Increased
29
Reduced
25
Closed
22

Top Buys

Rank Stock Value
1
GO icon
Grocery Outlet
GO
+$8.02M
2
QTWO icon
Q2 Holdings
QTWO
+$6.19M
3
RGEN icon
Repligen
RGEN
+$6.12M
4
CTLT
CATALENT, INC.
CTLT
+$6.02M
5
NFLX icon
Netflix
NFLX
+$5.48M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$14M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$9.31M
3
SAGE
Sage Therapeutics
SAGE
+$7.05M
4
OKTA icon
Okta
OKTA
+$6.25M
5
VAC icon
Marriott Vacations Worldwide
VAC
+$5.31M

Sector Composition

Rank Sector Weight
1 Healthcare 23.9%
2 Technology 17.5%
3 Communication Services 13.07%
4 Consumer Discretionary 11.14%
5 Materials 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASH icon
76
Ashland
ASH
$3.28B
– –
-38,000
Closed -$3.04M
ATEX icon
77
Anterix
ATEX
$1.94B
– –
-38,000
Closed -$1.79M
BCO icon
78
Brink's
BCO
$4.77B
– –
-47,000
Closed -$3.82M
CRWD icon
79
CrowdStrike
CRWD
$214B
– –
-308,000
Closed -$5.26M
GH icon
80
Guardant Health
GH
$21.9B
– –
-47,000
Closed -$4.06M
GOOS
81
Canada Goose Holdings
GOOS
$861M
– –
-100,000
Closed -$3.87M
IOVA icon
82
Iovance Biotherapeutics
IOVA
$1.94B
– –
-185,000
Closed -$4.54M
MOH icon
83
Molina Healthcare
MOH
$10.2B
– –
-12,000
Closed -$1.72M
RARE icon
84
Ultragenyx Pharmaceutical
RARE
$2.46B
– –
-28,000
Closed -$1.78M
RCKT icon
85
Rocket Pharmaceuticals
RCKT
$382M
– –
-102,600
Closed -$1.54M
SAGE
86
DELISTED
Sage Therapeutics
SAGE
– –
-38,500
Closed -$7.05M
SRPT icon
87
Sarepta Therapeutics
SRPT
$1.68B
– –
-92,000
Closed -$14M
TWLO icon
88
Twilio
TWLO
$29.3B
– –
-32,000
Closed -$4.36M
XYZ
89
Block Inc
XYZ
$50.1B
– –
-57,000
Closed -$4.13M
CTLT
90
CALL
DELISTED
CATALENT, INC.
CTLT
– –
-50,000
Closed -$2.71M
WORK
91
DELISTED
Slack Technologies, Inc.
WORK
– –
-129,000
Closed -$4.84M
GWPH
92
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-25,000
Closed -$4.31M
GWPH
93
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-54,000
Closed -$9.31M
VAR
94
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-19,000
Closed -$2.59M
ARQL
95
DELISTED
Arqule Inc
ARQL
– –
-317,000
Closed -$3.49M
1 2 3
4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
SC
Soundwatch Capital Rowayton, Connecticut $793M AUM 15.45% 1-Year Est. Return
LWM
Liberty Wealth Management Oakland, California $800M AUM 20.44% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return

Atika Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Atika Capital Management held 95 positions worth $475M, down 6.7% from $509M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Atika Capital Management's Q3 2019 filing shows 18 new, 29 increased, 25 reduced and 22 closed positions. Its largest new stake was Grocery Outlet: 211,500 shares worth $7.33M. The largest sale was Sarepta Therapeutics, an estimated $14M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.

  • Atika Capital Management's largest Q3 2019 buy was Grocery Outlet: 211,500 shares worth $7.33M.
  • Atika Capital Management added most to Netflix in Q3 2019, an estimated $5.48M increase.
  • Atika Capital Management's biggest Q3 2019 reduction was Okta, cutting an estimated $6.25M.
  • Atika Capital Management fully exited Sarepta Therapeutics in Q3 2019, selling an estimated $14M.
  • Atika Capital Management's ten largest holdings make up 32% of its $475M portfolio in Q3 2019.
  • Atika Capital Management opened 18 new positions and closed 22 in Q3 2019.
  • Atika Capital Management's portfolio value fell 6.7% quarter-over-quarter to $475M.

Based on Atika Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.